Follicular mycosis fungoides: successful treatment with oral bexarotene

Galina Shistik; Leigh Ann Scalf; Neil Fenske; L Frank Glass

Follicular mycosis fungoides: successful treatment with oral bexarotene

J Drugs Dermatol. 2004 May-Jun;3(3):301-4.

Authors

Galina Shistik¹, Leigh Ann Scalf, Neil Fenske, L Frank Glass

Affiliation

¹ Division of Dermatology, University of South Florida, Tampa, Florida, USA.

PMID: 15176165

Abstract

Follicular mycosis fungoides, a subtype of cutaneous T-cell lymphoma, is often difficult to treat. We present a case of a female with follicular mycosis fungoides who showed an excellent response to low-dose (150 mg/m2) oral bexarotene (Targretin). To our knowledge, this is the first reported case of follicular mycosis fungoides demonstrating a response to bexarotene.

Publication types

Case Reports

MeSH terms

Administration, Oral
Anticarcinogenic Agents / adverse effects
Anticarcinogenic Agents / therapeutic use*
Bexarotene
Female
Hair Follicle / pathology*
Humans
Middle Aged
Mycosis Fungoides / drug therapy*
Mycosis Fungoides / pathology
Tetrahydronaphthalenes / administration & dosage
Tetrahydronaphthalenes / therapeutic use*
Treatment Outcome

Substances

Anticarcinogenic Agents
Tetrahydronaphthalenes
Bexarotene